Home About People Research Publications Labs Tools Events ICT Contact Info

Research and Sharing

IIMO participates in the TCGA PanCancer Program, an international project, managed by National Cancer Institute at National Institutes of Health (NIH).

The IIMO has recently joined The Clinical Proteomic Tumor Analysis Consortium (CPTAC) is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. CPTAC is a multicenter and interdisciplinary project coordinated by National Cancer Institute at NIH. The IIMO has been awarded 4-years contract from NIH funded by federal funds from government of the United States.

IIMO collaborates with Cancer Research Institute in Lausanne on various arieas of the applied cancer research.

Dissimination of Knowledge

IIMO is registered at POL-on system as the International Scientific Institute. IIMO is also registered at NIH eRA Commons grant management system and as research organisation fully eligible to receive funding from the government of the USA.
IIMO is registered at the PLUS-IP platform (US State Dept) and actively participates in further development of this initiative.

In March 2016 the Institute is hosting Dr Jo Anne Zujewski, director of Breast Cancer Therapeutics, in the Clinical Investigation Branch of the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute. Dr Zujewski is the scientific liaison and disease expert for breast cancer clinical trials sponsored by the CTEP program of the NCI at NIH. Dr Zujewski has obtained the fellowship from US Department of State as visiting professor at IIMO.

IIMO participates in PhD Program of the Postgraduate School of Molecular Medicine of Warsaw University of Medicine.

IIMO is co-organiser of 8th International Conference of Contemporary Oncology Integrated Oncology: Genomics, Immunotherapies, and Molecular Targets Poznan, 16-18th of March 2016. Joint meeting of Polish Oncology Consortium, The University of Texas MD Anderson Cancer Center in Houston, Institute Gustave Roussy in Paris, International Institute of Molecular Oncology, Poznan, Poznan University of Medical Sciences, and Greater Poland Cancer Centre, Poznan.
Conference Poster
Conference Program

Implementation of Research

IIMO commercial partners are:
Telbud S.A.
INFO BAZA Technology